| Old Articles: <Older 6271-6280 Newer> |
|---|
 |
BusinessWeek
April 1, 2010
Kerry Capell |
Remote Health Care: Body Parts Make Phone Calls Facing saturated markets, cellular carriers are jumping into the revolution of mobile technology that identifies and acts on medical problems.   |
BusinessWeek
April 1, 2010
Bennett & Randall |
Will an AIDS Pill a Day Keep the Virus Away? Drugmaker Gilead is betting the one-pill PrEP treatment will slow the virus' spread - as are some of the world's top health agencies and philanthropists. |
The Motley Fool
April 1, 2010
Rich Smith |
This Just In: Upgrades and Downgrades Jesup and Collins are just a couple of fools in love ... with Human Genome Sciences. |
Investment Advisor
April 2010
Vaughan Scully |
The ETF Advisor: Prospects for Healthcare ETFs Better Than Those for Reform There are about two dozen exchange traded funds that offer a wide variety of exposures to the healthcare sector, including broad-based, global, and leveraged ETFs, as well as those targeting individual industries. |
The Motley Fool
March 31, 2010
Brian Orelli |
A Double-Digit Jump? For That? Isis' drug discovery license doesn't look too exciting to me. |
The Motley Fool
March 31, 2010
Brian Orelli |
When One Patent Means So Much The loss of patents on genes could have far-reaching consequences for drug companies. |
The Motley Fool
March 31, 2010
Brian Orelli |
How Do You Put a Price on Pain? Price controls could wreck havoc on expensive therapies that control pain. |
The Motley Fool
March 30, 2010
Brian Orelli |
FDA Lags, Investors Flee Cephalon gets no love from the FDA. The agency failed to expand Cephalon's Nuvigil for the treatment of jet lag. |
The Motley Fool
March 30, 2010
Brian Orelli |
Invest in This Space at Your Own Risk Lung cancer is a tough foe for drugmakers. |
The Motley Fool
March 30, 2010
Brian Orelli |
Your Biotech's Cash Burn Just Went Down Tucked inside the hundreds of pages of the health-care reform bill, is a nice little bonus for a select group of drugmakers. |
| <Older 6271-6280 Newer> Return to current articles. |
